Press

Intervacc AB (publ) has held its Annual General Meeting (”AGM”) on Wednesday 14 May 2025, at which the following resolutions were made.

Intervacc AB (publ) announces today that its distribution partner, Dechra Pharmaceuticals PLC ("Dechra"), will launch Strangvac^® in Finland and vaccine vials are expected to be available for delivery shortly. ... Read more

The shareholders of Intervacc AB (publ), reg. no. 556238-1748 (the “Company”), are hereby invited to the Annual General Meeting (“AGM”) to be held on Wednesday 14 May 2025 at 3.00 p.m. at Cirio Advokatbyrå, ... Read more

Intervacc AB (publ) announces that the company's 2024 Annual Report has been published today. The annual report (in Swedish) is attached and an English unaudited translation of the report is available for download on ... Read more

Intervacc AB (publ) today announces that the variation application previously submitted to the U.K’s Veterinary Medicines Directorate, (VMD), has now been approved. The approval concerns improved methods and processes ... Read more